Lantus pen– Insulin Glargine for Long-Acting Blood Sugar Control
Lantus pen provides consistent, long-acting blood sugar control for patients with diabetes mellitus. This insulin glargine formulation maintains stable basal insulin levels for up to 24 hours. Patients achieve steady glucose management, reduced risk of hyperglycemia, and improved overall glycemic control.
Doctors prescribe Lantus for adults and children with type 1 diabetes and adults with type 2 diabetes requiring long-acting insulin. Lantus works slowly after injection, forming a microprecipitate under the skin that releases insulin steadily. Patients inject once daily at the same time each day to maintain predictable insulin levels. Lantus integrates seamlessly into basal-bolus therapy or standalone regimens, supporting flexible diabetes management.
Patients use Lantus to stabilize fasting blood sugar and prevent spikes between meals and overnight. Its consistent action reduces the frequency of hypoglycemia episodes compared to intermediate-acting insulins. Healthcare providers monitor glucose levels to adjust doses for optimal outcomes. Lantus enables patients to maintain daily routines while managing diabetes effectively.
Clinical trials show Lantus improves HbA1c levels, stabilizes fasting glucose, and enhances long-term glycemic control. Patients report improved energy, reduced fatigue, and better quality of life. Its long-acting profile complements rapid-acting insulins, providing balanced blood sugar coverage throughout the day.
Lantus pen
Lantus comes in prefilled SoloStar pens or vials, offering precision dosing and convenience. Patients gain confidence from accurate measurements and easy administration. The formulation emphasizes patient safety, predictable absorption, and consistent therapeutic results. Lantus remains a trusted choice for endocrinologists and patients seeking reliable basal insulin therapy.
Product Specifications
| Specification | Details |
|---|---|
| Active Ingredient | Insulin Glargine |
| Formulation | Injectable solution |
| Strength | 100 units/mL |
| Dosage Form | Prefilled pen or vial |
| Indication | Type 1 diabetes (all ages), Type 2 diabetes (adults) |
| Administration | Subcutaneous injection, once daily |
| Duration of Action | Up to 24 hours |
| Mechanism of Action | Provides steady basal insulin |
| Storage Conditions | Store in refrigerator 2–8°C, do not freeze |
| Common Side Effects | Hypoglycemia, injection site reactions |
| Prescription Requirement | Prescription only |
Lantus empowers patients to manage diabetes confidently. Its long-lasting effect, reliable dosing, and proven efficacy support daily life and long-term health outcomes.
Reviews
There are no reviews yet.